1元甩卖股权！肿瘤医院无人接盘

Core Viewpoint - Yonghe Intelligent Control is attempting to publicly transfer 100% equity of Kunming Medical Oncology Hospital for a base price of 17 million yuan, marking the fourth attempt to sell this asset after previous unsuccessful attempts at higher prices [1][2]. Group 1: Financial Performance - Kunming Medical Oncology Hospital has consistently reported losses since its establishment in 2017, with a total loss of 4.97 million yuan in 2024 and an increased loss of 6.59 million yuan from January to July 2025 [1][2][3]. - The hospital's total assets as of July 31, 2025, were 84.55 million yuan, with total liabilities of 52.10 million yuan, resulting in net assets of 32.45 million yuan [2]. - The operating revenue for the first seven months of 2025 was 11.58 million yuan, while the operating profit was -5.35 million yuan, indicating ongoing financial struggles [2]. Group 2: Acquisition and Investment Strategy - Yonghe Intelligent Control acquired Kunming Medical Oncology Hospital in 2020 for 108 million yuan, as part of a broader strategy to expand into the healthcare sector [1][6]. - The company planned to establish a network of 50 oncology specialty hospitals across China, with initial investments estimated between 50 million to 70 million yuan per hospital [6][9]. - The company has also attempted to transfer stakes in other hospitals, with the latest transfer price for 70% of Liangshan High-tech Oncology Hospital set at 1.87 million yuan, and stakes in Dazhou and Xi'an Medical Oncology Hospitals listed for only 1 yuan [1][2]. Group 3: Market Context and Challenges - The oncology hospital sector in China has significant revenue potential, with total income for oncology hospitals reaching 104.99 billion yuan in 2022, averaging 656 million yuan per hospital [3][9]. - Despite the high demand for oncology services, Yonghe Intelligent Control's strategy of relying on equipment rather than clinical expertise has proven ineffective, as the company has faced challenges in patient acquisition and operational management [9][11]. - The competitive landscape for private oncology hospitals is tough, with many struggling to achieve profitability, highlighting the difficulties in the healthcare market [9][11].